SCHEMBL24083358

SCHEMBL24083358

C[C@H](CC1=CNNN1)OCC(=O)OC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22315716 0.69 APLNR (0.31) —
SCHEMBL22316960 0.69 APLNR (0.31) —
SCHEMBL22995886 0.67 KDM4E (0.42) —
SCHEMBL2080034 0.67 CYP2D6 (0.40) —
SCHEMBL4537683 0.66 CYP2D6 (0.35) —
SCHEMBL24083357 0.65 — —
SCHEMBL22315709 0.64 CYP2D6 (0.33) —
SCHEMBL13359076 0.64 HDAC3 (0.36) —
SCHEMBL26084660 0.64 CYP2D6 (0.33) —
SCHEMBL29004730 0.62 CYP2D6 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3919498-A1 PYRROLOPYRIMIDINE DERIVATIVE AND USE THEREOF Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) 2021-12-08 — — EP disclosed
Send feedback